PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Langmuir0 citations

Spatially Controlled, Wirefree, Drug Release along a Single PEDOT Film

View Full Paper
ÁBÁine BradyEBEwa BieniaszRFRobert Forster

Key Points

  • This research aims to develop a wire-free method for controlled drug release using conducting polymer films.
  • Electrodeposited thin PEDOT films were loaded with fluorescein and exposed to an electric field of approximately 0.6 V cm–1.
  • Spatial modulation of the PEDOT oxidation state was used to control the release of fluorescein.
  • The method was designed for applications requiring targeted drug delivery to minimize irritation or toxicity.
  • The spatial variance in drug release along the PEDOT film allows for programmable release profiles.
  • Directional drug elution was achieved, with a gradient from low-to-high release across the film.
  • Reconfiguring the external electric field enables dynamic adjustments in the drug release zones postdeployment.

Abstract

A wire-free bipolar electrochemical strategy for spatially resolved release of encapsulated molecules from within a conducting polymer film is described. Thin electrodeposited PEDOT films were loaded with fluorescein and exposed to an externally generated electric field (∼0.6 V cm–1), creating a longitudinal potential gradient within the PEDOT film. The resulting spatial variation in PEDOT oxidation state modulates fluorescein release, producing programmable, region-dependent release along the single continuous film. This enables directional drug elution (low-to-high release across the film) without the need for wires, embedded electronics, or segmented reservoirs. This, wirefree, spatially nonuniform drug release enables applications where the drug needs to be delivered preferentially to one tissue, e.g., to reduce irritation or toxicity to adjacent healthy tissue, e.g., ocular inserts, periodontal chips, wound dressings, stents, orthopedic implants etc., where a drug release is only beneficial on one area of the device. Moreover, reconfiguring the external field distribution provides a route to translate the release zone over time enabling dynamic targeting postdeployment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Brady et al. (2026) studied this question.

synapsesocial.com/papers/6a095ac47880e6d24efe0a9ehttps://doi.org/10.1021/acs.langmuir.6c00755
Ask AI
Helpful
Bookmark
Share
View Full Paper